SSR411298
SSR411298 is an orally active, selective and reversible fatty acid amide hydrolase (FAAH) inhibitor. SSR411298 has the potential for post-traumatic stress disorder research[1].
Product Specifications
CAS Number
[666860-59-9]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
FAAH
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/ssr411298.html
Purity
99.75
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COC1=CC2=C(C=C1)C([C@@H]3CO[C@H](OC3)CCCNC(OCC(N)=O)=O)=CC=C2
Molecular Formula
C21H26N2O6
Molecular Weight
402.44
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Guy Griebel, et al. The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents. Sci Rep. 2018 Feb 5;8 (1) :2416.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
248573-ML490 100 µL
MBNL1 (Muscleblind-like (Drosophila), DKFZp686P06174, EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL) (MaxLight 490)
Ask
View Details